Statistics for Pulse Biosciences (id:5459 PLSE)

Valuation metrics

Market cap

1.01B

Enterprise value

952.97M

Trailing P/E (ttm)

-18.65

Forward P/E

-18.31

PEG ratio

-18.31

Price/Sales (ttm)

Price/Book (mrq)

12.81

Enterprise Value/Revenue

Enterprise Value/EBITDA

-20.13

Overview

Shares outstanding

61.52M

Float

17.23M

Shares short

2.54M

% Held by insiders

0.72%

% Held by institutions

0.09%

Average volume (10 days)

236.25K

Average volume (90 days)

Price summary

52-Week low

6.51

52-Week high

22.69

52-Week change

58.55%

Beta

1.75

50-Day moving average

17.34

200-Day moving average

13.14

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-38.15%

Return on equity

-70.28%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-47,334,000.00

Net income to common (ttm)

-46,133,000.00

Diluted EPS (ttm)

-0.83

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

79.03M

Total cash per share (mrq)

1.28

Total debt (mrq)

8.37M

Total Debt/Equity (mrq)

10.57

Current ratio (mrq)

1.19K%

Book value per share (mrq)

1.29

Cash flow

Cash flow statement

-33,981,000.00

Levered free cash flow (LFCF)

-18,813,124.00